(Yicai) Feb. 5 -- China has struck back against the executive order of US President Donald Trump to impose 10 percent tariffs on Chinese imports with a series of countermeasures, including retaliatory tariffs, new export controls, and a dispute filing with the World Trade Organization.

China will impose additional tariffs on certain US imports starting Feb. 10, including 15 percent on coal and liquefied natural gas and 10 percent on crude oil, agricultural machinery, large-displacement vehicles, and pickup trucks, the Customs Tariff Commission of the State Council announced yesterday.

On the same day, China's Ministry of Commerce and the General Administration of Customs jointly announced new export controls on materials related to tungsten, tellurium, bismuth, molybdenum, and indium. The ministry also added Calvin Klein's US owner PVH and California-based biotechnology firm Illumina to its unreliable entity list.

In addition, the commerce ministry said China has filed a case against the US tariff measures under the WTO dispute settlement mechanism to defend its legitimate rights and interests.

The US tariffs on Chinese imports seriously violate WTO rules and represent typical unilateralism and trade protectionism, a commerce ministry spokesperson noted. The US actions severely undermine the rules-based multilateral trading system, damage the foundation of China-US economic and trade cooperation, and disrupt global supply chains, the person added.

China firmly opposes these actions and urges the US to immediately correct its wrongful practices, the spokesperson stressed.

Regarding the US imposing 10 percent tariffs on imports from China due to fentanyl concerns, a Chinese Embassy spokesperson said that the Asian country has one of the world's strictest anti-drug policies, pointing out that China became the first country to implement a class-wide scheduling of fentanyl substances at US request in 2019, with the pair having extensively cooperated in the area. The US should take an objective and rational approach to addressing its domestic fentanyl issues, the person noted.

Editor: Martin Kadiev